These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to [email protected] and [email protected]. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

Gene therapy gets big pharma endorsement

Gene therapy is poised to make a commercial breakthrough after Oxford BioMedica agreed global rights for a cancer treatment with Sanofi-Aventis, in a deal with a headline value of €518 million.
27 Mar 2007
News